A Comparison of Cognitive and Dynamic Therapy for Depression in Community Settings

This study is currently recruiting participants.
Verified June 2012 by University of Pennsylvania
Sponsor:
Information provided by (Responsible Party):
Mary Beth Gibbons, Ph.D., University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT01207271
First received: September 21, 2010
Last updated: June 26, 2012
Last verified: June 2012

September 21, 2010
June 26, 2012
November 2010
July 2014   (final data collection date for primary outcome measure)
Hamilton Rating Scale for Depression (HAM-D) [ Time Frame: 6 months ] [ Designated as safety issue: No ]
Symptomatic level of depression as measured by the Hamilton Rating Scale for Depression (HAM-D) [ Time Frame: Baseline, Month 1, Month 2, Month 4, Month 6 ] [ Designated as safety issue: No ]
Complete list of historical versions of study NCT01207271 on ClinicalTrials.gov Archive Site
  • BASIS-24 [ Time Frame: 6 months ] [ Designated as safety issue: No ]
  • Beck Depression Inventory - II (BDI-II) [ Time Frame: 6 months ] [ Designated as safety issue: No ]
  • Medical Outcomes Study 36-Item Short Form (SF-36) [ Time Frame: 6 months ] [ Designated as safety issue: No ]
    Measure of general functionality
  • Quality of Life Inventory (QOLI) [ Time Frame: 6 months ] [ Designated as safety issue: No ]
  • Ways of Responding (WOR) [ Time Frame: 2 months ] [ Designated as safety issue: No ]
  • Dysfunctional Attitudes Scale (DAS) [ Time Frame: 2 months ] [ Designated as safety issue: No ]
  • Psychological Distance Scaling Task (PDST) [ Time Frame: 2 months ] [ Designated as safety issue: No ]
  • Self-Understanding of Interpersonal Patterns Scale-Revised (SUIP-R) [ Time Frame: 2 months ] [ Designated as safety issue: No ]
  • Symptomatic level of depression and general functionality as measured by the BASIS-24 [ Time Frame: Baseline, Weekly, Month 1, Month 2, Month 4, Month 6 ] [ Designated as safety issue: No ]
  • Symptomatic level of depression and general functionality as measured by the Beck Depression Inventory - II (BDI-II) [ Time Frame: Baseline, Weekly, Month 1, Month 2, Month 4, Month 6 ] [ Designated as safety issue: No ]
  • General functionality as measured by the Medical Outcomes Study 36-Item Short Form (SF-36) [ Time Frame: Baseline, Month 1, Month 2, Month 4, Month 6 ] [ Designated as safety issue: No ]
  • Quality of life as measured by the Quality of Life Inventory (QOLI) [ Time Frame: Baseline, Month 1, Month 2, Month 4, Month 6 ] [ Designated as safety issue: No ]
Not Provided
Not Provided
 
A Comparison of Cognitive and Dynamic Therapy for Depression in Community Settings
A Comparison of Cognitive and Dynamic Therapy for MDD in Community Settings

The goal of this study is to compare supportive-expressive therapy, a type of psychodynamic psychotherapy, with cognitive therapy for the treatment of depression in community mental health consumers.

Hypothesized mediators of treatment will also be examined.

The goal of this study is to conduct a randomized, comparative, non-inferiority clinical trial that tests the hypothesis that a widely used form of manualized dynamic psychotherapy (supportive-expressive psychodynamic therapy) is not inferior to cognitive therapy when implemented in community mental health settings for the treatment of major depressive disorder (MDD). The specific aims are (1) to conduct a randomized non-inferiority trial to compare supportive-expressive psychodynamic therapy and cognitive therapy for patients with MDD and (2) to assess the comparative effectiveness of supportive-expressive psychodynamic therapy and cognitive therapy on secondary measures of symptoms, patient functioning, and quality of life.

Patient mediators of outcome will also be examined through an additional grant awarded to Paul Crits-Christoph, Ph.D. This grant was funded by the National Institutes of Mental Health - RO1MH092363-01. This grant is entitled:"The mechanisms of cognitive and dynamic therapy in community settings."

Recruitment will occur solely through community mental health clinics in and around Philadelphia.

Interventional
Phase 3
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Major Depressive Disorder
  • Behavioral: Cognitive Therapy
    16 sessions of cognitive therapy administered weekly by a community mental health therapist
    Other Names:
    • Cognitive Behavioral Therapy
    • CBT
  • Behavioral: Supportive-Expressive Psychodynamic Therapy
    16 sessions of supportive-expressive psychodynamic therapy administered weekly by a community mental health therapist
    Other Names:
    • Psychodynamic Psychotherapy
    • Short Term Dynamic Therapy
  • Experimental: Cognitive Therapy
    Intervention: Behavioral: Cognitive Therapy
  • Experimental: Dynamic Therapy
    Intervention: Behavioral: Supportive-Expressive Psychodynamic Therapy
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
230
July 2014
July 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Confirmed diagnosis of major depressive disorder
  • Able to read at the 4th grade level or higher
  • Willingness to be randomized and participate in research

Exclusion Criteria:

  • Current or past diagnosis of schizophrenia, seizure disorder, bipolar disorder, psychotic features, or clinically significant organic pathology
  • Significant suicidal risk/ideation requiring immediate referral for more intensive treatment, or specific gesture in the last 6 months
  • Current substance abuse or dependence requiring immediate referral to substance abuse program
  • Acute medical problem requiring immediate inpatient treatment
  • Need for referral to a partial hospitalization program
Both
18 Years to 65 Years
No
Contact: Tessa Mooney, B.A. 215-349-5222 mooneyt@mail.med.upenn.edu
United States
 
NCT01207271
R01HS018440
Yes
Mary Beth Gibbons, Ph.D., University of Pennsylvania
University of Pennsylvania
Not Provided
Principal Investigator: Mary Beth Gibbons, Ph.D. University of Pennsylvania
Principal Investigator: Paul Crits-Christoph, Ph.D. University of Pennsylvania
University of Pennsylvania
June 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP